Literature DB >> 30790410

The impact of age and ageing on hepatocarcinoma surgery: Short- and long-term outcomes in a multicentre propensity-matched cohort.

Simone Famularo1,2, Stefano Di Sandro2, Alessandro Giani1,3, Marco Angrisani1,3, Andrea Lauterio2, Fabrizio Romano1,3, Luca Gianotti1,3, Luciano De Carlis1,2.   

Abstract

BACKGROUND: Management of malignancy in elderly patients is challenging. We aimed to assess the impact of age and ageing on overall survival (OS), recurrence-free survival (RFS), tumour-specific survival (TSS) and potential years of life lost (PYLL) after surgery for hepatocarcinoma (HCC).
METHODS: Consecutive patients treated for HCC between 2005 and 2015 were evaluated. Patients were divided according to age-decade. Afterwards, elderly patients (≥75 years) were compared with patients < 75 years. A 1:1 propensity matching was used to reduce the risk of bias. Survival was estimated by Kaplan-Meier method and Cox regression analysis.
RESULTS: Four hundred and thirty-nine patients were stratified: group 1 (age ≤ 55, n = 72), group 2 (age: 56-65, n = 133), group 3 (age: 66-74, n = 141) and group 4 (age ≥ 75, n = 93). Group 1 had the highest median PYLL (27.6, IQR 24.6-32.5) while group 4 the lowest (2.0, IQR 0-9.6; P < 0.001). Comparing elderly vs younger, there were no significant differences in terms of OS (P = 0.054), TSS (P = 0.321) and RFS (P = 0.240). Ageing was the only variable associated with post-operative complications (OR: 2.51; 95% CI: 1.23-5.13; P = 0.025) and liver-related morbidity was an independent predictor of OS. (HR 2.49, 95% CI: 1.34-4.64, P = 0.004).
CONCLUSION: Ageing per se is not an absolute contraindication for liver resection, given the acceptable oncologic long-term prognosis, but the worse short-term outcomes in the elderly should induce an accurate patient selection.
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  HCC; age; ageing; elderly; outcomes; potential years of life lost; surgery; survival

Year:  2019        PMID: 30790410     DOI: 10.1111/liv.14075

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  5 in total

1.  Outcomes of Geriatric Patients with Hepatocellular Carcinoma.

Authors:  Chern-Horng Lee; Tzung-Hai Yen; Sen-Yung Hsieh
Journal:  Curr Oncol       Date:  2022-06-16       Impact factor: 3.109

2.  Impact of Postoperative Complications on Long-Term Survival After Resection of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Authors:  Junjie Kong; Guangbing Li; Jiawei Chai; Guangsheng Yu; Yong Liu; Jun Liu
Journal:  Ann Surg Oncol       Date:  2021-06-23       Impact factor: 5.344

3.  Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study.

Authors:  Jia-Le Pu; Zhong Chen; Lan-Qing Yao; Ji-Ye Feng; Yong-Kang Diao; Ming-Cheng Guan; Ju-Dong Li; Zheng-Liang Chen; Ya-Hao Zhou; Hong Wang; Wei-Min Gu; Jie Li; Chao Li; Ming-Da Wang; Hong Zhu; Ying-Jian Liang; Feng Shen; Timothy M Pawlik; Wan Yee Lau; Tian Yang
Journal:  BJS Open       Date:  2022-01-06

Review 4.  How to Treat Hepatocellular Carcinoma in Elderly Patients.

Authors:  Piera Federico; Emilio Francesco Giunta; Annalisa Pappalardo; Andrea Tufo; Gianpaolo Marte; Laura Attademo; Antonietta Fabbrocini; Angelica Petrillo; Bruno Daniele
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-08

5.  Major hepatectomy for perihilar cholangiocarcinoma in elderly patients: is it reasonable?

Authors:  L Ripamonti; R De Carlis; A Lauterio; I Mangoni; S Frassoni; V Bagnardi; L Centonze; C Poli; V Buscemi; F Ferla; L De Carlis
Journal:  Updates Surg       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.